Asset Management One’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Asset Management One's NVAX Position: Q2 2022 in Review
Asset Management One sold out of Novavax (NVAX) in Q2 2022, closing a stake of 30,192 shares — an estimated $2.22M sold.
Asset Management One first reported a position in NVAX in Q4 2015 and held it in 7 quarters. The position peaked at $6.52M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- Asset Management One reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- Asset Management One sold 30,192 Novavax shares in Q2 2022, an estimated $2.22M.
- Asset Management One first reported a position in Novavax in Q4 2015 and held it in 7 quarters.
- Asset Management One's Novavax position peaked at $6.52M in Q2 2021.
- 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on Asset Management One's 13F filing for Q2 2022, filed 29 Jul 2022.